Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Sterling Investment Advisors Ltd.

Sterling Investment Advisors Ltd. cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 0.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 19,915 shares of the company’s stock after selling 115 shares during the period. Sterling Investment Advisors Ltd.’s holdings in Cardinal Health were worth $2,355,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. State Street Corp raised its stake in Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the period. Two Sigma Advisers LP raised its stake in Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after purchasing an additional 346,362 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its stake in Cardinal Health by 230.0% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock worth $52,819,000 after purchasing an additional 333,095 shares during the period. Worldquant Millennium Advisors LLC raised its stake in Cardinal Health by 77.3% during the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company’s stock worth $65,539,000 after purchasing an additional 258,541 shares during the period. Finally, Pacer Advisors Inc. raised its stake in Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $127.43 on Tuesday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The company has a market capitalization of $30.78 billion, a P/E ratio of 23.77, a PEG ratio of 1.49 and a beta of 0.63. The company’s fifty day moving average is $123.84 and its two-hundred day moving average is $117.53.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. UBS Group boosted their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $138.40.

Get Our Latest Research Report on Cardinal Health

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.